Myelo Therapeutics

Business Data, Corporate Office and Headquarter Address

About

Myelo Therapeutics is Biotechnology in Germany that focus on chemotherapy regimens business. Founded in 2013. They cover business area such as developer, innovative adjuvant cancer therapy, CIN, patient, various cancer type, chemotherapy regimen, physician, benefit.

Business Type

Biotechnology

Country

Germany

Founded

2013
( 11 years old in 2024 )

Company Focus

Chemotherapy Regimens

Website

-

Corporate Office and Headquarter Office address:

Rheinsberger Strasse 7
10115 Berlin
Germany

Phone number:

Private

Office Opening Hours*:

Monday 9.30 - 17.00
Tuesday 9.30 - 17.00
Wednesday 9.30 - 17.00
Thursday 9.30 - 17.00
Friday 9.30 - 17.00
Saturday Closed
Sunday Closed

Business Coverage

developerinnovative adjuvant cancer therapyCINpatientvarious cancer typechemotherapy regimenphysicianbenefit

* We use standard office opening hours in near Myelo Therapeutics's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.

Myelo Therapeutics Frequently Asked Questions

What or who is Myelo Therapeutics?

Myelo Therapeutics is Biotechnology business from Germany that founded in 2013 (11 years old in 2024), Myelo Therapeutics business is focusing on Chemotherapy Regimens.

Where is Myelo Therapeutics headquarter and corporate office address?

Myelo Therapeutics headquarter office and corporate office address is located in Rheinsberger Strasse 7 10115 Berlin Germany.

Where is Myelo Therapeutics country origins?

Myelo Therapeutics was founded in Germany.

What is Chemotherapy Regimens business focus on?

In 2024, Myelo Therapeutics is currently focus on chemotherapy regimens sector.

Chemotherapy Regimens Business Interest from Google Trend

Above is snippet of Google Trends for "chemotherapy regimens" term, if you have problem loading the snippet, please visit here: Google Trend.

Disclaimer: This website is not affiliated with Myelo Therapeutics, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.